Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Bloom Burton & Co. is a prominent healthcare investment firm founded in Canada, dedicated to identifying, cultivating, and creating investment opportunities within the healthcare sector. Established with a vision to enhance the healthcare landscape, Bloom Burton & Co. has built a reputation for its comprehensive approach to investment, which includes raising capital, providing mergers and acquisitions advisory, and offering strategic advisory services. The firm operates primarily in North America, with a strong emphasis on the Canadian market.
With a focus on various stages of investment, Bloom Burton & Co. engages with companies from pre-seed through to growth equity, ensuring that they support innovative healthcare solutions at every phase of development. The firm is particularly well-regarded for its expertise in biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, healthcare IT, life science tools, animal health, nutrition, and wellness. This diverse investment strategy allows Bloom Burton & Co. to maintain a robust portfolio that reflects the dynamic nature of the healthcare industry.
Bloom Burton & Co. is also known for hosting the annual Bloom Burton & Co. Healthcare Investor Conference, which showcases over 60 Canadian publicly-traded and venture-backed private companies, as well as promising pre-venture companies. This event not only highlights the firm’s commitment to the healthcare sector but also serves as a platform for networking and collaboration among industry stakeholders. Additionally, the firm recognizes outstanding contributions to the healthcare industry through the annual Bloom Burton Award, further solidifying its role as a leader in healthcare investment.
Bloom Burton & Co. has a well-defined investment focus that spans multiple sectors within the healthcare industry. The firm actively seeks opportunities in biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, healthcare IT, life science tools, animal health, nutrition, and wellness. By concentrating on these areas, Bloom Burton & Co. aims to support innovative companies that are poised to make significant impacts in the healthcare landscape.
The firm invests across a wide range of stages, including pre-seed, seed, Series A, Series B, Series C, and growth equity. This flexibility allows Bloom Burton & Co. to engage with startups and established companies alike, providing them with the necessary capital and strategic guidance to thrive. The firm is particularly interested in companies that demonstrate strong potential for growth and innovation, as well as those that align with their mission to enhance healthcare outcomes.
In addition to financial investment, Bloom Burton & Co. offers a comprehensive suite of services to its portfolio companies. These services include capital raising, mergers and acquisitions advisory, equity research, sales and trading, and strategic advisory. By providing this level of support, the firm not only invests in companies but also partners with them to ensure their long-term success in the competitive healthcare market.
Bloom Burton & Co. boasts a diverse portfolio that reflects its commitment to the healthcare sector. The firm is known for hosting the Bloom Burton & Co. Healthcare Investor Conference, which features over 60 Canadian publicly-traded and venture-backed private companies, as well as promising pre-venture companies in the healthcare space. This conference serves as a significant platform for showcasing innovative healthcare solutions and fostering connections within the industry.
In addition to its conference activities, Bloom Burton & Co. recognizes outstanding contributions to the healthcare industry through the annual Bloom Burton Award. This award highlights the achievements of companies and individuals who have made a significant impact in healthcare, further emphasizing the firm’s dedication to supporting and promoting excellence within the sector.
While specific details about individual investments and exits are not provided, the firm’s active engagement in the healthcare landscape and its focus on various stages of investment suggest a robust portfolio that includes a mix of early-stage and growth-stage companies. Bloom Burton & Co. continues to seek out promising opportunities that align with its investment thesis, ensuring a dynamic and impactful portfolio.
Bloom Burton & Co. has recently been active in promoting their annual Healthcare Investor Conference, with registration now open for the 2026 event. This conference is a key opportunity for healthcare companies to showcase their innovations and connect with potential investors. Additionally, the firm has published several blog posts covering significant public offerings by companies in their portfolio, as well as updates on the Canadian healthcare landscape, indicating ongoing engagement with industry developments.
Bloom Burton & Co. invests across a wide range of stages, including pre-seed, seed, Series A, Series B, Series C, and growth equity. This diverse stage focus allows the firm to engage with companies at various points in their development, providing tailored support and capital as needed.
The firm primarily focuses on the healthcare sector, with specific interests in biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, healthcare IT, life science tools, animal health, nutrition, and wellness. This broad sector focus enables Bloom Burton & Co. to support a variety of innovative companies within the healthcare landscape.
While specific details about the pitch process are not provided, it is advisable for founders to prepare a comprehensive pitch that outlines their business model, market potential, and how their company aligns with Bloom Burton & Co.'s investment focus in healthcare. Engaging with the firm through networking events, such as their Healthcare Investor Conference, may also provide opportunities for introductions.
Bloom Burton & Co. primarily invests in North America, with a strong emphasis on the Canadian market. This geographic focus allows the firm to leverage its local expertise and network to identify promising healthcare investment opportunities.
In addition to financial investment, Bloom Burton & Co. offers a range of services to its portfolio companies, including capital raising, mergers and acquisitions advisory, equity research, and strategic advisory. This comprehensive support helps companies navigate the complexities of the healthcare market and enhances their chances of success.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.